In the latest trading session, Exact Sciences (EXAS) closed at $72.26, marking a +0.81% move from the previous day. This change lagged the S&P 500’s 2.57% gain on the day. Elsewhere, the Dow gained 2%, while the tech-heavy Nasdaq added 0.3%.
Prior to today’s trading, shares of the molecular diagnostics company had lost 8.98% over the past month. This has lagged the Medical sector’s loss of 4.45% and the S&P 500’s loss of 7.68% in that time.
Wall Street will be looking for positivity from Exact Sciences as it approaches its next earnings report date. On that day, Exact Sciences is projected to report earnings of -$1.12 per share, which would represent a year-over-year decline of 522.22%. Meanwhile, our latest consensus estimate is calling for revenue of $461.86 million, up 14.87% from the prior-year quarter.
For the full year, our Zacks Consensus Estimates are projecting earnings of -$4.33 per share and revenue of $2.01 billion, which would represent changes of -24.43% and +13.51%, respectively, from the prior year.
Any recent changes to analyst estimates for Exact Sciences should also be noted by investors. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the company’s business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 27.33% lower within the past month. Exact Sciences is currently a Zacks Rank #3 (Hold).
The Medical – Biomedical and Genetics industry is part of the Medical sector. This group has a Zacks Industry Rank of 155, putting it in the bottom 39% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
5 Stocks Set to Double
Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2021. Previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report
